Harpreet Singh, Ph.D

Chief Executive Officer

Dr Harpreet Singh co-founded Immatics Biotechnologies GmbH, the parent company of Immatics US, Inc. in 2000 during his PhD studies. Since then he has served over 15 years as Managing Director and Chief Scientific Officer of Immatics GmbH dedicated to the translation…

read more

Steffen Walter, Ph.D

Chief Scientific Officer

Dr Steffen Walter co-founded Immatics US, Inc. and joined it in 2015 as Chief Scientific Officer. In 2005, Dr Walter joined Immatics Biotechnologies GmbH, the parent company of Immatics US, Inc., as Director and Head of Immunology and later VP Immunology after having…

read more

Toni Weinschenk, Ph.D

Chief Technology Officer

Since more than fifteen years, Dr Toni Weinschenk is active in the field of cancer immunology with focus on discovery of HLA-presented peptides from native tumor and normal tissues by mass spectrometry. He is regarded the world’s leading expert in ultra-high…

read more

Carsten Reinhardt, M.D. Ph.D

Chief Medical Officer

Dr Carsten Reinhardt joined Immatics Biotechnologies GmbH in October 2009 from Micromet, Inc. (Bethesda, MD), where he was Chief Medical Officer. Before becoming a member of Micromet´s management board in 2005, Dr Reinhardt had global responsibility for Herceptin®…

read more

Rainer Kramer, Ph.D

Chief Business Officer

Dr Rainer Kramer joined Immatics as Chief Business Officer in April 2012 from Signature Diagnostics AG where he was Chief Business Officer as well. He is primarily responsible for Immatics’ licensing & partnering activities. During his career he has delivered…

read more